» Articles » PMID: 32572858

Post-polypectomy Colonoscopy Surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Abstract

The following recommendations for post-polypectomy colonoscopic surveillance apply to all patients who had one or more polyps that were completely removed during a high quality baseline colonoscopy. 1: ESGE recommends that patients with complete removal of 1 - 4 < 10 mm adenomas with low grade dysplasia, irrespective of villous components, or any serrated polyp < 10 mm without dysplasia, do not require endoscopic surveillance and should be returned to screening.Strong recommendation, moderate quality evidence.If organized screening is not available, repetition of colonoscopy 10 years after the index procedure is recommended.Strong recommendation, moderate quality evidence. 2: ESGE recommends surveillance colonoscopy after 3 years for patients with complete removal of at least 1 adenoma ≥ 10 mm or with high grade dysplasia, or ≥ 5 adenomas, or any serrated polyp ≥ 10 mm or with dysplasia. Strong recommendation, moderate quality evidence. 3: ESGE recommends a 3 - 6-month early repeat colonoscopy following piecemeal endoscopic resection of polyps ≥ 20 mm.Strong recommendation, moderate quality evidence. A first surveillance colonoscopy 12 months after the repeat colonoscopy is recommended to detect late recurrence.Strong recommendation, high quality evidence. 4: If no polyps requiring surveillance are detected at the first surveillance colonoscopy, ESGE suggests to perform a second surveillance colonoscopy after 5 years. Weak recommendation, low quality evidence.After that, if no polyps requiring surveillance are detected, patients can be returned to screening. 5: ESGE suggests that, if polyps requiring surveillance are detected at first or subsequent surveillance examinations, surveillance colonoscopy may be performed at 3 years. Weak recommendation, low quality evidence.A flowchart showing the recommended surveillance intervals is provided (Fig. 1).

Citing Articles

Surveillance colonoscopy after resection of large polyps: Can we reduce loss to follow up?.

Madhu D, Siau K Endosc Int Open. 2025; 13:a24010777.

PMID: 39958663 PMC: 11827735. DOI: 10.1055/a-2401-0777.


Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer.

Kane L, Flood B, Manils J, McSkeane D, Smith A, Tosetto M Gastro Hep Adv. 2025; 4(2):100552.

PMID: 39866724 PMC: 11760840. DOI: 10.1016/j.gastha.2024.09.007.


Diverticulosis and neoplastic lesions in screening colonoscopy: a large, multicenter study.

Fedeli P, Masotti M, Marzano C, Dezi A, Scaccianone G, Martinelli E Ann Gastroenterol. 2025; 38(1):68-71.

PMID: 39802296 PMC: 11724387. DOI: 10.20524/aog.2024.0928.


Colorectal Cancer Incidence and Mortality After Negative Colonoscopy Screening Results.

Knudsen M, Wang K, Wang L, Polychronidis G, Berstad P, Hjartaker A JAMA Oncol. 2024; 11(1):46-54.

PMID: 39602147 PMC: 11603378. DOI: 10.1001/jamaoncol.2024.5227.


Study protocol: the 'Endoscope CRC' cohort, a prospective biobank study on the development and evaluation of diagnostic and prognostic biomarker profiles for colorectal cancer and premalignant lesions.

Cheng H, van Vorstenbosch R, Jonkers D, Masclee A, Schoon E, van Schooten F BMJ Open. 2024; 14(11):e083229.

PMID: 39542477 PMC: 11660323. DOI: 10.1136/bmjopen-2023-083229.